Abstract
“Heparin” has been and is still used with four different meanings, depending on the author: (1) any heat-stable naturally occurring anticoagulant activity (neutralized by protamine, etc.); (2) a sulfated mucopolysaccharide present in tissues, highly metachromatic, with a high critical electrolyte concentration, with mast cells; (3) a commercial drug of varying composition and activities; and (4) a sulfated mucopolysaccharide with distinctive chemical and biologic properties. I have discussed the problem of a term having different meanings in different disciplines (9). The four definitions of “heparin” are those of the hematologist, the histologist, the clinician-pharmacologist, and the biochemist. To our regret, the first definition is still found in the literature. The second definition will be applicable later in these proceedings. This portion of the conference is directed to the third and fourth definitions, and the third shades imperceptibly into the fourth. The basic difficulty for Drs. Jeanloz, Cifonelli, and Brozovic has been the relation in operational terms of these definitions. One must work with the “heparin” of the third definition. Does the heparin in the fourth definition exist? This question caused the controversy between Jorpes and Charles and Scott in 1937–1939, and it must still trouble any serious workers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bangham, D.R. and Woodward, P.M., Bull. Wld. Hlth. Org., 42 (1970) 129.
Blake, O., Ashwin, J. and Jaques, L.B., J. Clin. Path., 12 (1959) 118.
Charles, A.F. and Todd, A.R., Biochem. J., 34 (1940) 112.
Hashimoto, K. and Matsuno, M., Tohoku J. Exp. Med., 91 (1967) 295.
Hashimoto, K., Matsuno, M., Yosizawa, Z. and Shibata, T., Tohoku J. Exp. Med., 81 (1963) 93.
Helbert, J.R. and Marini, M.A., Biochemistry 2, 5 (1963) 1101.
Jaques, L.B., Ph.D. Thesis, University of Toronto, (1941).
Jaques, L.B., 22nd Annual Wayne State University Symp. on Blood (1974) in press.
Jaques, L.B., Thromb. Diath. Haem. Suppl., 46 (1971) 21.
Jaques, L.B., Thromb. Diath. Haem. 9, Suppl. 2 (1963) 27.
Jaques, L.B. and Bell, H.J., Methods of Biochemical Analysis, Interscience Publishers, Inc., New York, 7 (1959) 253.
Jaques, L.B. and Charles, A.F., Quart. J. Pharm, and Pharmacol. 14 (1941) 43.
Jaques, L.B., Kavanagh, L.W. and Lavallee, A., Arzneimittel Forsch., 17 (1967) 774.
Jaques, L.B., Waters, E.T. and Charles, A.F., J. Biol. Chem., 144 (1944) 229.
Jorpes, E. and Bergstrom, S., Biochem. J., 33 (1939) 47.
Kavanagh, L.W. and Jaques, L.B., Arzneimittel-Forsch., 23 (1973) 605.
Kuo, S.H., Jaques, L.B. and Millar, G.J., J. Pharm. Pharmacol., 24 (1972) 858.
Nader, H.B., McDuffie, N.M. and Dietrich, C.P., Biochem. Biophys. Res. Comm., (1974) in press.
Ottoson, R. and Snellman, O., Acta Chem. Scand., 13 (1959) 473.
Scott, J.E., Patent Specification No. 1221784, The Patent Office, London, 1971.
Winterstein, A., Pharmaceutisch Weekblad., 92 (1957) 982.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Jaques, L.B. (1975). What is “Heparin”?. In: Bradshaw, R.A., Wessler, S. (eds) Heparin. Advances in Experimental Medicine and Biology, vol 52. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0946-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0946-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0948-2
Online ISBN: 978-1-4684-0946-8
eBook Packages: Springer Book Archive